+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Strabismus Drug"

Strabismus Treatment Apparatus Global Market Report 2025 - Product Thumbnail Image

Strabismus Treatment Apparatus Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Strabismus is a condition in which the eyes do not align properly, resulting in a misalignment of the visual axes. Optical Disorders Drugs are used to treat strabismus, and the Strabismus Drug market is a subset of the larger Optical Disorders Drug market. Strabismus Drugs are used to treat the underlying cause of the misalignment, such as muscle imbalance or nerve damage. These drugs can be administered orally, topically, or through injections. Commonly used Strabismus Drugs include botulinum toxin, cycloplegic agents, and anticholinesterase agents. The Strabismus Drug market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Allergan, Novartis, Pfizer, Merck, and Santen Pharmaceuticals. Show Less Read more